Coronary MDCTA With Iopamidol Injection 370

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bracco Diagnostics, Inc

Criteria

Inclusion Criteria:

• Provide informed consent

• At least 30 years of age

• Weight less than 250 lbs

• Known or suspected coronary artery disease and suspected to have significant coronary artery stenosis

• Undergo MDCTA scan

• Undergo coronary angiography within 2 weeks of MDCTA scan

Exclusion Criteria:

• Hx of hypersensitivity to iodinated contrast agents

• Known or suspected hyperthyroidism or pheochromocytoma

• Renal impairment

• History of coronary artery stent placement or bypass grafts

• Unstable

• Pregnant or lactating